Literature DB >> 29533199

Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus.

Marjorie M Walker1, Michael Potter2, Nicholas J Talley3.   

Abstract

Under normal physiological conditions, eosinophils are present throughout the gastrointestinal tract distal to the squamous oesophagus. Increases in their numbers signify primary and secondary eosinophilic conditions. The rare primary eosinophilic diseases eosinophilic gastroenteritis and eosinophilic colitis affect fewer than ten in 100 000 people, and are characterised by numerous mucosal eosinophils, distributed in sheets and sometimes extending from the mucosa into the submucosa. Pathogenesis of these diseases is poorly understood, but food allergies and intestinal dysbiosis have been implicated. Presentation ranges from vague abdominal symptoms and systemic complaints to, rarely, an acute abdomen with intestinal obstruction. Diagnosis is made from mucosal biopsy samples taken at endoscopy or from surgically resected specimens that demonstrate substantially increased numbers of eosinophils. Eosinophilia secondary to other conditions, such as pathogenic infections, must be excluded. Subtle eosinophilia has also been identified in the duodenum in functional dyspepsia and in the colon in spirochaetosis. Treatment of eosinophilic gastroenteritis and eosinophilic colitis is based on evidence from case reports and small case series, and first-line therapy includes empirical food-elimination diets and single courses of steroids, whereas relapsing or refractory disease might respond to steroid-sparing immunosuppressive agents and biological agents. The progression of disease in eosinophilic gastroenteritis and eosinophilic colitis is variable: a considerable number of patients have just one episode without relapse, whereas others have relapsing-remitting or chronic disease. Primary and secondary eosinophilia in the gastrointestinal tract is increasingly recognised as a clinical conundrum waiting to be solved.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29533199     DOI: 10.1016/S2468-1253(18)30005-0

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  20 in total

1.  Eosinophilic Gastroenteritis and Colitis: Not Yet Ready for the Big Leagues.

Authors:  Noam Zevit; Glenn T Furuta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-07       Impact factor: 2.839

2.  Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study.

Authors:  Tetsuo Shoda; Ting Wen; Julie M Caldwell; Margaret H Collins; John A Besse; Garrett A Osswald; J Pablo Abonia; Nicoleta C Arva; Dan Atkins; Kelley E Capocelli; Evan S Dellon; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; Vincent A Mukkada; Philip E Putnam; Rachel M Sheridan; Amanda K Rudman Spergel; Jonathan M Spergel; Joshua B Wechsler; Guang-Yu Yang; Seema S Aceves; Glenn T Furuta; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2019-11-16       Impact factor: 10.793

3.  Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab.

Authors:  Tanja Grandinetti; Luc Biedermann; Christian Bussmann; Alex Straumann; Petr Hruz
Journal:  Dig Dis Sci       Date:  2019-04-13       Impact factor: 3.199

4.  Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium.

Authors:  Robert D Pesek; Craig C Reed; Amanda B Muir; Patricia C Fulkerson; Calies Menard-Katcher; Gary W Falk; Jonathan Kuhl; Ellen K Martin; Adam Z Magier; Faria Ahmed; Maureen Demarshall; Ankur Gupta; Jonathan Gross; Tokunbo Ashorobi; Christina L Carpenter; Jeffrey P Krischer; Nirmala Gonsalves; Jonathan M Spergel; Sandeep K Gupta; Glenn T Furuta; Marc E Rothenberg; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2019-06       Impact factor: 10.864

5.  Follow-Up of a Rare Case of Eosinophilic Gastroenteritis Associated with Persistent Blood Eosinophilia and Multiple Food Allergies.

Authors:  Polliana Mihaela Leru; Vlad Florin Anton; Ioana Adriana Muntean; Carmen Daniela Neagoe; Dumitru Matei
Journal:  Diagnostics (Basel)       Date:  2022-06-02

Review 6.  Eosinophilic Gastritis/Gastroenteritis.

Authors:  Phillip H Chen; Lorraine Anderson; Kuixing Zhang; Guy A Weiss
Journal:  Curr Gastroenterol Rep       Date:  2021-07-30

Review 7.  Histopathology of Non-IBD Colitis. A practical approach from the Italian Group for the study of the gastrointestinal tract (GIPAD).

Authors:  Vincenzo Villanacci; Luca Reggiani-Bonetti; Giuseppe Leoncini; Paola Parente; Moris Cadei; Luca Albarello; Giulio Mandelli; Alessandro Caputo
Journal:  Pathologica       Date:  2021-02

8.  Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field.

Authors:  Marc E Rothenberg; Shawna K B Hottinger; Nirmala Gonsalves; Glenn T Furuta; Margaret H Collins; Nicholas J Talley; Kathryn Peterson; Calies Menard-Katcher; Macie Smith; Ikuo Hirano; Robert M Genta; Mirna Chehade; Sandeep K Gupta; Jonathan M Spergel; Seema S Aceves; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2021-12-22       Impact factor: 10.793

9.  Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases.

Authors:  Craig C Reed; Corey J Ketchem; Talya L Miller; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2021-05-28       Impact factor: 11.382

10.  Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis.

Authors:  Craig C Reed; Robert M Genta; Bradford A Youngblood; Joshua B Wechsler; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-12       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.